Latest On Syneos Health, Inc (SYNH):
About Syneos Health, Inc (SYNH):
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various services spanning Phases I to IV of clinical development, including full service global studies, as well as individual service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services comprising deployment solutions; communications solutions, such as public relations, advertising, and medical communications; and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a partnership with VBI Vaccines Inc. for the commercialization of 3-antigen prophylactic hepatitis B vaccine in the United States, Europe, and Canada, which is in pending regulatory approvals. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina
General
- Name Syneos Health, Inc
- Symbol SYNH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 24,310
- Fiscal Year EndDecember
- IPO Date2014-11-07
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://www.syneoshealth.com
Valuation
- Trailing PE 41.67
- Forward PE 17.79
- Price/Sales (Trailing 12 Mt.) 1.85
- Price/Book (Most Recent Quarter) 2.47
- Enterprise Value Revenue 2.48
- Enterprise Value EBITDA 21.2
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $4.25
- Next Year EPS Estimate $4.83
- Next Quarter EPS Estimate $0.90
- Profit Margin 4%
- Operating Margin 8%
- Return on Assets 3%
- Return on Equity 6%
- Revenue 4.42 billion
- Earnings Per Share $1.83
- Revenue Per Share $42.39
- Gross Profit 1.02 billion
- Quarterly Earnings Growth -6%
Highlights
- Market Capitalization 7.91 billion
- EBITDA 575.15 million
- PE Ratio 29.73
- PEG Ratio 2.02
- Analyst Target Price $86.36
- Book Value Per Share $31.19
Share Statistics
- Shares Outstanding 103.69 million
- Shares Float 84 million
- % Held by Insiders 21%
- % Held by Institutions 98.01%
- Shares Short 4.74 million
- Shares Short Prior Month 4.48 million
- Short Ratio 7.01
- Short % of Float 8%
- Short % of Shares Outstanding 5%
Technicals
- Beta 1.81
- 52 Week High $81.35
- 52 Week Low $32.64
- 50 Day Moving Average 75.63
- 200 Day Moving Average 66.27
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Syneos Health, Inc (SYNH) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Syneos Health, Inc (SYNH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-18 | $1.14 billion | $1.11 | $1.10 | 0.74% |
2020-09-30 | 2020-10-29 | $N/A | $1.04 | $0.90 | 15.77% |
2020-06-30 | 2020-08-06 | $N/A | $0.58 | $0.49 | 18.17% |
2020-03-31 | 2020-04-30 | $N/A | $0.68 | $0.64 | 6.9% |
2019-12-31 | 2020-02-20 | $1.21 billion | $1.03 | $1.01 | 1.73% |
2019-09-30 | 2019-10-31 | $1.18 billion | $0.87 | $0.82 | 5.58% |
2019-06-30 | 2019-08-06 | $1.17 billion | $0.74 | $0.70 | 5.52% |
2019-03-31 | 2019-05-09 | $1.12 billion | $0.59 | $0.61 | -2.7% |
2018-12-31 | 2019-03-18 | $1.15 billion | $0.95 | $0.82 | 16.34% |
2018-09-30 | 2018-11-06 | $1.11 billion | $0.75 | $0.68 | 10.72% |
2018-06-30 | 2018-08-02 | $1.07 billion | $0.62 | $0.61 | 1.39% |
2018-03-31 | 2018-05-09 | $1.06 billion | $0.55 | $0.52 | 5.38% |
2017-12-31 | 2018-02-28 | $1.08 billion | $0.70 | $0.56 | 24.22% |
2017-09-30 | 2017-11-09 | $822.33 million | $0.54 | $0.62 | -12.92% |
2017-06-30 | 2017-07-27 | $391.14 million | $0.64 | $0.64 | 0.09% |
2017-03-31 | 2017-05-10 | $381.92 million | $0.60 | $0.59 | 1.04% |
2016-12-31 | 2017-02-28 | $406.07 million | $0.67 | $0.67 | 0.18% |
2016-09-30 | 2016-10-31 | $391.79 million | $0.78 | $0.63 | 24.86% |
2016-06-30 | 2016-07-28 | $399.65 million | $0.61 | $0.58 | 5.96% |
2016-03-31 | 2016-05-02 | $413.09 million | $0.58 | $0.54 | 8.31% |
2015-12-31 | 2016-02-25 | $402.89 million | $0.54 | $0.49 | 9.36% |
2015-09-30 | 2015-10-29 | $350.15 million | $0.58 | $0.44 | 31.82% |
2015-06-30 | 2015-07-30 | $337.29 million | $0.47 | $0.34 | 38.24% |
2015-03-31 | 2015-04-27 | $308.92 million | $0.42 | $0.28 | 50% |
2014-12-31 | 2015-02-24 | $327.66 million | $0.26 | $0.21 | 23.81% |
2014-09-30 | 2014-11-07 | $298.62 million | $0.35 |
Syneos Health, Inc (SYNH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Syneos Health, Inc (SYNH) Chart:
Syneos Health, Inc (SYNH) News:
Below you will find a list of latest news for Syneos Health, Inc (SYNH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Syneos Health, Inc (SYNH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest SYNH Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 11 | $64.54 |
Jun 13, 2022 7:59 PM EST | 73 | $64.5 |
Jun 13, 2022 7:59 PM EST | 21 | $64.5 |
Jun 13, 2022 7:59 PM EST | 2 | $64.53 |
Jun 13, 2022 7:59 PM EST | 100 | $64.48 |
Syneos Health, Inc (SYNH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000113/0001610950-20-000113-index.htm |
2019-10-29 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1610950/000000000019014950/0000000000-19-014950-index.htm |
2019-11-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1610950/000000000019015640/0000000000-19-015640-index.htm |
2019-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610950/000021545719005866/0000215457-19-005866-index.htm |
2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610950/000083423720006789/0000834237-20-006789-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610950/000093247119006163/0000932471-19-006163-index.htm |
2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610950/000110465920018457/0001104659-20-018457-index.htm |
2018-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036118026131/0001140361-18-026131-index.htm |
2018-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036118026132/0001140361-18-026132-index.htm |
2018-08-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1610950/000114036118036234/0001140361-18-036234-index.htm |
2018-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036118036238/0001140361-18-036238-index.htm |
2018-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036118036241/0001140361-18-036241-index.htm |
2018-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036118038579/0001140361-18-038579-index.htm |
2018-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036118038582/0001140361-18-038582-index.htm |
2018-09-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036118038982/0001140361-18-038982-index.htm |
2019-05-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036119010012/0001140361-19-010012-index.htm |
2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036119010018/0001140361-19-010018-index.htm |
2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036119010019/0001140361-19-010019-index.htm |
2019-06-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1610950/000114036119011699/0001140361-19-011699-index.htm |
2019-06-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036119011719/0001140361-19-011719-index.htm |
2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036119011721/0001140361-19-011721-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120012777/0001140361-20-012777-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120012778/0001140361-20-012778-index.htm |
2020-09-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021013/0001140361-20-021013-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021021/0001140361-20-021021-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021029/0001140361-20-021029-index.htm |
2020-09-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021045/0001140361-20-021045-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021060/0001140361-20-021060-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021061/0001140361-20-021061-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021062/0001140361-20-021062-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021064/0001140361-20-021064-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021065/0001140361-20-021065-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021066/0001140361-20-021066-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021067/0001140361-20-021067-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021068/0001140361-20-021068-index.htm |
2020-09-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021158/0001140361-20-021158-index.htm |
2020-09-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021161/0001140361-20-021161-index.htm |
2020-09-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021163/0001140361-20-021163-index.htm |
2020-09-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021167/0001140361-20-021167-index.htm |
2020-09-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021169/0001140361-20-021169-index.htm |
2020-09-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021172/0001140361-20-021172-index.htm |
2018-06-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1610950/000119312518185600/0001193125-18-185600-index.htm |
2018-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312518209673/0001193125-18-209673-index.htm |
2018-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312518238316/0001193125-18-238316-index.htm |
2018-08-06 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1610950/000119312518239827/0001193125-18-239827-index.htm |
2018-08-08 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1610950/000119312518242819/0001193125-18-242819-index.htm |
2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312518242847/0001193125-18-242847-index.htm |
2018-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312518252277/0001193125-18-252277-index.htm |
2018-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312518326751/0001193125-18-326751-index.htm |
2018-11-27 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1610950/000119312518335283/0001193125-18-335283-index.htm |
2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312518346257/0001193125-18-346257-index.htm |
2019-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312519005465/0001193125-19-005465-index.htm |
2019-02-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312519025885/0001193125-19-025885-index.htm |
2019-02-27 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1610950/000119312519054321/0001193125-19-054321-index.htm |
2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312519090662/0001193125-19-090662-index.htm |
2019-04-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1610950/000119312519104490/0001193125-19-104490-index.htm |
2019-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312519157027/0001193125-19-157027-index.htm |
2019-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312519230928/0001193125-19-230928-index.htm |
2019-11-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1610950/000119312519288488/0001193125-19-288488-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312519289999/0001193125-19-289999-index.htm |
2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312519308425/0001193125-19-308425-index.htm |
2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312520007808/0001193125-20-007808-index.htm |
2020-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312520010151/0001193125-20-010151-index.htm |
2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312520099877/0001193125-20-099877-index.htm |
2020-09-15 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1610950/000119312520246323/0001193125-20-246323-index.htm |
2020-09-16 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1610950/000119312520247291/0001193125-20-247291-index.htm |
2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000119312520247413/0001193125-20-247413-index.htm |
2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000120919120041771/0001209191-20-041771-index.htm |
2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000120919120041773/0001209191-20-041773-index.htm |
2020-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042504/0001209191-20-042504-index.htm |
2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042895/0001209191-20-042895-index.htm |
2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000120919120044737/0001209191-20-044737-index.htm |
2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000120919120056689/0001209191-20-056689-index.htm |
2019-02-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000151390019000003/0001513900-19-000003-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000151390020000002/0001513900-20-000002-index.htm |
2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000156459020037002/0001564590-20-037002-index.htm |
2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000156459020037010/0001564590-20-037010-index.htm |
2020-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000156459020048439/0001564590-20-048439-index.htm |
2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000156459020048443/0001564590-20-048443-index.htm |
2018-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095018000028/0001610950-18-000028-index.htm |
2018-08-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000161095018000030/0001610950-18-000030-index.htm |
2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095018000034/0001610950-18-000034-index.htm |
2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000161095018000038/0001610950-18-000038-index.htm |
2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095018000043/0001610950-18-000043-index.htm |
2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095018000044/0001610950-18-000044-index.htm |
2019-02-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000002/0001610950-19-000002-index.htm |
2019-03-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000008/0001610950-19-000008-index.htm |
2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000010/0001610950-19-000010-index.htm |
2019-04-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000015/0001610950-19-000015-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000022/0001610950-19-000022-index.htm |
2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000023/0001610950-19-000023-index.htm |
2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000024/0001610950-19-000024-index.htm |
2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000025/0001610950-19-000025-index.htm |
2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000026/0001610950-19-000026-index.htm |
2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000027/0001610950-19-000027-index.htm |
2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000028/0001610950-19-000028-index.htm |
2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000029/0001610950-19-000029-index.htm |
2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000035/0001610950-19-000035-index.htm |
2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000036/0001610950-19-000036-index.htm |
2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000048/0001610950-19-000048-index.htm |
2019-10-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000050/0001610950-19-000050-index.htm |
2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000052/0001610950-19-000052-index.htm |
2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000055/0001610950-19-000055-index.htm |
2019-11-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000056/0001610950-19-000056-index.htm |
2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000057/0001610950-19-000057-index.htm |
2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000059/0001610950-19-000059-index.htm |
2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000061/0001610950-19-000061-index.htm |
2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000002/0001610950-20-000002-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000009/0001610950-20-000009-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000010/0001610950-20-000010-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000011/0001610950-20-000011-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000012/0001610950-20-000012-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000013/0001610950-20-000013-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000014/0001610950-20-000014-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000021/0001610950-20-000021-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000022/0001610950-20-000022-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000023/0001610950-20-000023-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000024/0001610950-20-000024-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000025/0001610950-20-000025-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000029/0001610950-20-000029-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000030/0001610950-20-000030-index.htm |
2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000031/0001610950-20-000031-index.htm |
2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000034/0001610950-20-000034-index.htm |
2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000035/0001610950-20-000035-index.htm |
2020-02-20 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000043/0001610950-20-000043-index.htm |
2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000044/0001610950-20-000044-index.htm |
2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000048/0001610950-20-000048-index.htm |
2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000049/0001610950-20-000049-index.htm |
2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000050/0001610950-20-000050-index.htm |
2020-04-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000061/0001610950-20-000061-index.htm |
2020-04-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000062/0001610950-20-000062-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000064/0001610950-20-000064-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000067/0001610950-20-000067-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000071/0001610950-20-000071-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000073/0001610950-20-000073-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000075/0001610950-20-000075-index.htm |
2020-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000083/0001610950-20-000083-index.htm |
2020-04-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000084/0001610950-20-000084-index.htm |
2020-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000087/0001610950-20-000087-index.htm |
2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000089/0001610950-20-000089-index.htm |
2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000091/0001610950-20-000091-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000101/0001610950-20-000101-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000102/0001610950-20-000102-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000103/0001610950-20-000103-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000104/0001610950-20-000104-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000105/0001610950-20-000105-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000106/0001610950-20-000106-index.htm |
2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000110/0001610950-20-000110-index.htm |
2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000113/0001610950-20-000113-index.htm |
2018-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407318000004/0001624073-18-000004-index.htm |
2018-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407318000005/0001624073-18-000005-index.htm |
2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000002/0001624073-19-000002-index.htm |
2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000003/0001624073-19-000003-index.htm |
2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000004/0001624073-19-000004-index.htm |
2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000005/0001624073-19-000005-index.htm |
2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000006/0001624073-19-000006-index.htm |
2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000007/0001624073-19-000007-index.htm |
2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000008/0001624073-19-000008-index.htm |
2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000009/0001624073-19-000009-index.htm |
2018-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067018000005/0001660670-18-000005-index.htm |
2018-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067018000006/0001660670-18-000006-index.htm |
2018-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067018000007/0001660670-18-000007-index.htm |
2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067019000001/0001660670-19-000001-index.htm |
2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067019000002/0001660670-19-000002-index.htm |
2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067019000003/0001660670-19-000003-index.htm |
2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067019000004/0001660670-19-000004-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000166067020000010/0001660670-20-000010-index.htm |
2018-11-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000167302518000001/0001673025-18-000001-index.htm |
2018-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000167302518000002/0001673025-18-000002-index.htm |
2018-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000167302518000003/0001673025-18-000003-index.htm |
2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000167302519000001/0001673025-19-000001-index.htm |
2019-02-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000176603619000003/0001766036-19-000003-index.htm |
2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610950/000176603619000004/0001766036-19-000004-index.htm |
Syneos Health, Inc (SYNH) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syneos Health, Inc (SYNH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 21%Institutional Ownership: 9801%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-09-17 | THOMAS H. LEE ADVISORS, LLC | Director | Sell | 203.00 | 59.26 | 12,029.78 | 1,005.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021021/0001140361-20-021021-index.htm |
2018-11-13 | Jonathan Olefson | General Counsel & Corp Secty | Buy | 10,564.00 | 10,564.00 | https://www.sec.gov/Archives/edgar/data/1610950/000167302518000002/0001673025-18-000002-index.htm | ||
2020-05-27 | THOMAS H. LEE ADVISORS, LLC | Director | Buy | 2,803.00 | 11,028.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036120012778/0001140361-20-012778-index.htm | ||
2018-12-17 | Jonathan Olefson | General Counsel & Corp Secty | Buy | 750.00 | 41.27 | 30,954.75 | 11,314.00 | https://www.sec.gov/Archives/edgar/data/1610950/000167302518000003/0001673025-18-000003-index.htm |
2019-05-24 | Linda S Harty | Director | Buy | 4,122.00 | 42.45 | 174,978.90 | 11,432.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000025/0001610950-19-000025-index.htm |
2019-05-24 | WILLIAM E KLITGAARD | Director | Buy | 4,122.00 | 42.45 | 174,978.90 | 11,432.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000026/0001610950-19-000026-index.htm |
2019-05-24 | Kenneth F Meyers | Director | Buy | 4,122.00 | 42.45 | 174,978.90 | 12,141.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000027/0001610950-19-000027-index.htm |
2019-05-24 | Matthew E. Monaghan | Director | Buy | 4,122.00 | 42.45 | 174,978.90 | 12,141.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000028/0001610950-19-000028-index.htm |
2020-04-20 | Robert Parks | EVP, Chief Accounting Officer | Sell | 3,588.00 | 49.65 | 178,144.20 | 12,450.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000084/0001610950-20-000084-index.htm |
2020-05-27 | Linda S Harty | Director | Buy | 2,803.00 | 62.43 | 174,991.29 | 14,235.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000106/0001610950-20-000106-index.htm |
2020-05-27 | WILLIAM E KLITGAARD | Director | Buy | 2,803.00 | 62.43 | 174,991.29 | 14,235.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000104/0001610950-20-000104-index.htm |
2020-05-27 | Kenneth F Meyers | Director | Buy | 2,803.00 | 62.43 | 174,991.29 | 14,944.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000103/0001610950-20-000103-index.htm |
2020-05-27 | Matthew E. Monaghan | Director | Buy | 2,803.00 | 62.43 | 174,991.29 | 14,944.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000101/0001610950-20-000101-index.htm |
2020-01-17 | Robert Parks | EVP, Chief Accounting Officer | Buy | 4,135.00 | 15,661.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000031/0001610950-20-000031-index.htm | ||
2020-09-17 | THOMAS H. LEE ADVISORS, LLC | Director | Sell | 3,232,987.00 | 59.26 | 191,586,809.62 | 16,006,677.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021021/0001140361-20-021021-index.htm |
2020-04-20 | Robert Parks | EVP, Chief Accounting Officer | Buy | 377.00 | 44.48 | 16,768.96 | 16,038.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000084/0001610950-20-000084-index.htm |
2020-07-06 | John M. Dineen | Director | Buy | 8,691.00 | 59.11 | 513,725.01 | 17,426.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120041771/0001209191-20-041771-index.htm |
2018-12-10 | John M. Dineen | Director | Buy | 1,630.00 | 1,810.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095018000044/0001610950-18-000044-index.htm | ||
2020-09-17 | INTERNATIONAL CORP/MA ADVENT | 10% Share Holder | Sell | 3,766,281.00 | 59.26 | 223,189,812.06 | 18,647,036.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021068/0001140361-20-021068-index.htm |
2020-09-17 | John L. Maldonado | Director | Sell | 3,766,281.00 | 59.26 | 223,189,812.06 | 18,647,036.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021061/0001140361-20-021061-index.htm |
2020-09-17 | Tom Allen | Director | Sell | 3,766,281.00 | 59.26 | 223,189,812.06 | 18,647,036.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021065/0001140361-20-021065-index.htm |
2019-11-12 | Bernadette Connaughton | Director | Buy | 1,909.00 | 49.48 | 94,457.32 | 1,909.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000057/0001610950-19-000057-index.htm |
2018-08-09 | THOMAS H. LEE ADVISORS, LLC | 10% Share Holder | Sell | 6,000,000.00 | 49.73 | 298,380,000.00 | 19,239,664.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036118036241/0001140361-18-036241-index.htm |
2019-01-08 | Jonathan Olefson | General Counsel & Corp Secty | Buy | 10,068.00 | 21,382.00 | https://www.sec.gov/Archives/edgar/data/1610950/000167302519000001/0001673025-19-000001-index.htm | ||
2019-02-05 | Alistair Macdonald | Chief Executive Officer | Sell | 6,697.00 | 53.04 | 355,202.18 | 224,004.00 | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000005/0001624073-19-000005-index.htm |
2019-02-13 | Alistair Macdonald | Chief Executive Officer | Sell | 8,143.00 | 53.00 | 431,579.00 | 224,004.00 | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000006/0001624073-19-000006-index.htm |
2019-02-05 | Alistair Macdonald | Chief Executive Officer | Buy | 6,697.00 | 8.45 | 56,589.65 | 230,701.00 | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000005/0001624073-19-000005-index.htm |
2019-02-13 | Alistair Macdonald | Chief Executive Officer | Buy | 8,143.00 | 8.45 | 68,808.35 | 232,147.00 | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000006/0001624073-19-000006-index.htm |
2019-01-08 | Alistair Macdonald | Chief Executive Officer | Buy | 64,812.00 | 233,854.00 | https://www.sec.gov/Archives/edgar/data/1610950/000162407319000002/0001624073-19-000002-index.htm | ||
2020-01-15 | Alistair Macdonald | Chief Executive Officer | Buy | 48,770.00 | 244,968.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000025/0001610950-20-000025-index.htm | ||
2020-08-03 | Alistair Macdonald | Chief Executive Officer | Sell | 10,289.00 | 65.07 | 669,464.07 | 246,687.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120044737/0001209191-20-044737-index.htm |
2020-03-05 | Alistair Macdonald | Chief Executive Officer | Buy | 31,258.00 | 248,937.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000071/0001610950-20-000071-index.htm | ||
2020-01-15 | PAUL COLVIN | Pres., Clinical Solutions | Buy | 11,862.00 | 25,555.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000022/0001610950-20-000022-index.htm | ||
2020-01-15 | Jonathan Olefson | General Counsel & Corp Secty | Buy | 6,692.00 | 25,932.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000021/0001610950-20-000021-index.htm | ||
2020-03-05 | Alistair Macdonald | Chief Executive Officer | Buy | 12,217.00 | 261,154.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000071/0001610950-20-000071-index.htm | ||
2020-07-13 | Alistair Macdonald | Chief Executive Officer | Sell | 3,655.00 | 58.21 | 212,746.59 | 261,154.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042504/0001209191-20-042504-index.htm |
2020-07-14 | Alistair Macdonald | Chief Executive Officer | Sell | 373.00 | 59.15 | 22,061.83 | 261,154.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042504/0001209191-20-042504-index.htm |
2020-07-15 | Alistair Macdonald | Chief Executive Officer | Sell | 18,934.00 | 60.14 | 1,138,747.56 | 261,154.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042895/0001209191-20-042895-index.htm |
2020-07-14 | Alistair Macdonald | Chief Executive Officer | Sell | 4,800.00 | 58.64 | 281,491.20 | 261,527.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042504/0001209191-20-042504-index.htm |
2020-09-17 | THOMAS H. LEE ADVISORS, LLC | Director | Sell | 529.00 | 59.26 | 31,348.54 | 2,619.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036120021021/0001140361-20-021021-index.htm |
2020-07-13 | Alistair Macdonald | Chief Executive Officer | Buy | 3,655.00 | 10.57 | 38,633.35 | 264,809.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042504/0001209191-20-042504-index.htm |
2020-07-14 | Alistair Macdonald | Chief Executive Officer | Buy | 5,173.00 | 10.57 | 54,678.61 | 266,327.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042504/0001209191-20-042504-index.htm |
2020-03-19 | PAUL COLVIN | Pres., Clinical Solutions | Buy | 1,300.00 | 36.65 | 47,645.00 | 26,855.00 | https://www.sec.gov/Archives/edgar/data/1610950/000151390020000002/0001513900-20-000002-index.htm |
2020-07-15 | Alistair Macdonald | Chief Executive Officer | Buy | 9,467.00 | 16.06 | 152,040.02 | 270,621.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042895/0001209191-20-042895-index.htm |
2020-03-05 | Jonathan Olefson | General Counsel & Corp Secty | Buy | 1,898.00 | 27,830.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000075/0001610950-20-000075-index.htm | ||
2020-07-15 | Alistair Macdonald | Chief Executive Officer | Buy | 18,934.00 | 16.06 | 304,080.04 | 280,088.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120042895/0001209191-20-042895-index.htm |
2020-03-05 | PAUL COLVIN | Pres., Clinical Solutions | Buy | 2,491.00 | 29,346.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000073/0001610950-20-000073-index.htm | ||
2018-12-17 | Jason M. Meggs | Chief Financial Officer | Buy | 3,650.00 | 41.25 | 150,562.50 | 38,265.00 | https://www.sec.gov/Archives/edgar/data/1610950/000166067018000007/0001660670-18-000007-index.htm |
2020-01-15 | MICHELLE KEEFE | Pres., Commercial Solutions | Buy | 11,862.00 | 45,781.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000024/0001610950-20-000024-index.htm | ||
2020-05-27 | Bernadette Connaughton | Director | Buy | 2,803.00 | 62.43 | 174,991.29 | 4,712.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000102/0001610950-20-000102-index.htm |
2020-07-06 | MICHELLE KEEFE | Pres., Commercial Solutions | Sell | 1,500.00 | 59.11 | 88,665.00 | 50,443.00 | https://www.sec.gov/Archives/edgar/data/1610950/000120919120041773/0001209191-20-041773-index.htm |
2020-03-05 | MICHELLE KEEFE | Pres., Commercial Solutions | Buy | 7,815.00 | 51,709.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000067/0001610950-20-000067-index.htm | ||
2020-05-20 | MICHELLE KEEFE | Pres., Commercial Solutions | Sell | 2,500.00 | 60.00 | 150,000.00 | 51,943.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000091/0001610950-20-000091-index.htm |
2020-03-05 | MICHELLE KEEFE | Pres., Commercial Solutions | Buy | 2,610.00 | 54,319.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000067/0001610950-20-000067-index.htm | ||
2020-03-05 | MICHELLE KEEFE | Pres., Commercial Solutions | Buy | 124.00 | 44.48 | 5,515.52 | 54,443.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000067/0001610950-20-000067-index.htm |
2019-01-08 | Jason M. Meggs | Chief Financial Officer | Buy | 16,524.00 | 54,789.00 | https://www.sec.gov/Archives/edgar/data/1610950/000166067019000001/0001660670-19-000001-index.htm | ||
2019-05-24 | John M. Dineen | Director | Buy | 4,122.00 | 42.45 | 174,978.90 | 5,932.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095019000024/0001610950-19-000024-index.htm |
2018-05-24 | THOMAS H. LEE ADVISORS, LLC | 10% Share Holder | Buy | 4,103.00 | 6,281.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036118026132/0001140361-18-026132-index.htm | ||
2020-01-15 | Jason M. Meggs | Chief Financial Officer | Buy | 13,803.00 | 63,463.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000023/0001610950-20-000023-index.htm | ||
2020-03-20 | Jason M. Meggs | Chief Financial Officer | Buy | 3,510.00 | 36.75 | 128,992.50 | 63,784.00 | https://www.sec.gov/Archives/edgar/data/1610950/000166067020000010/0001660670-20-000010-index.htm |
2020-03-20 | Jason M. Meggs | Chief Financial Officer | Buy | 45.00 | 36.00 | 1,620.00 | 63,829.00 | https://www.sec.gov/Archives/edgar/data/1610950/000166067020000010/0001660670-20-000010-index.htm |
2020-03-05 | Jason M. Meggs | Chief Financial Officer | Buy | 5,094.00 | 68,923.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000064/0001610950-20-000064-index.htm | ||
2020-03-05 | Jason M. Meggs | Chief Financial Officer | Buy | 3,115.00 | 72,038.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000064/0001610950-20-000064-index.htm | ||
2019-05-24 | THOMAS H. LEE ADVISORS, LLC | Director | Buy | 4,122.00 | 8,225.00 | https://www.sec.gov/Archives/edgar/data/1610950/000114036119010019/0001140361-19-010019-index.htm | ||
2020-05-27 | John M. Dineen | Director | Buy | 2,803.00 | 62.43 | 174,991.29 | 8,735.00 | https://www.sec.gov/Archives/edgar/data/1610950/000161095020000105/0001610950-20-000105-index.htm |